+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vifor Pharma - logo

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

Hyperkalemia Drugs Market 2024-2028 - Product Thumbnail Image

Hyperkalemia Drugs Market 2024-2028

  • Report
  • August 2024
  • 139 Pages
  • Global
From
From
Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 354 Pages
  • Global
From
From
From
From
From
Hyperphosphatemia Treatment Global Market Report 2024 - Product Thumbnail Image

Hyperphosphatemia Treatment Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029 - Product Thumbnail Image

Global IV & Oral Iron Drugs Market - Focused Insights 2024-2029

  • Report
  • February 2024
  • 126 Pages
  • Global
From
Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Iron Drugs - Global Strategic Business Report

  • Report
  • November 2024
  • 187 Pages
  • Global
From
Loading Indicator